Park Ha Biological Technology Co., Ltd. (BYAH) stock
Close on Nov 17, 2026Market cap $1.06MP/E –Yield –
Park Ha Biological Technology Co., Ltd. grew revenue 6.0% to $2.52M over fiscal 2025. Operating income fell 3142.5% to -$24.15M, moving the operating margin from 33.3% to -956.5%. Free cash flow was -$2.97K, down 100.3% from a year earlier. At the latest close the market valued the company at $1.06M.
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Apr 30, 2026
Valuation
- Market cap
- $1.06M
- P/E ratio
- –
- Price to sales
- 0.42
- Price to book
- 0.20
- Dividend yield
- –
- Free cash flow yield
- -0.28%
Fundamentals
- Revenue
- $2.52M
- Net income
- -$24.36M
- EPS, diluted
- -$41.38
- Free cash flow
- -$2.97K
Trading
- Previous close
- $1.48
- Open
- $1.42
- Day's range
- $1.39 – $1.65
- Volume
- 835,274
- Average volume (20 days)
- 224,873
- 52-week range
- $1.39 – $112.04
- RSI (14 days)
- 31.2
- Volatility (1 year)
- 199.7%
- Relative volume
- 0.13×
Market cap history
Month-end market cap since 2024, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 17, 2026. The S&P 500 is measured by the SPY fund.
| Period | BYAH | S&P 500 | Difference | BYAH per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -28.6% | -4.0% | −24.6 pts | ||
| 3 months | -47.0% | -5.0% | −42.0 pts | ||
| Year to date | -97.5% | +8.2% | −105.8 pts | ||
| 1 year | -98.5% | +11.2% | −109.8 pts |
Five years at a glance
Fiscal years 2021 to 2025, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Park Ha Biological Technology filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
About Park Ha Biological Technology
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
Park Ha Biological Technology Co., Ltd. operates within the beauty industry through its PRC subsidiaries. The company utilizes an Online-to-Offline (O2O) business model to drive consumers from digital marketing channels to physical brick-and-mortar locations. Its operations encompass beauty salons and centers, offering beauty services and related products to retail consumers and individual customers. In addition, the company engages in commercial franchise activities and provides management consulting services across its operating network.
Company profile, executives and historyPark Ha Biological Technology stock: common questions
What is Park Ha Biological Technology's stock price?
BYAH closed at $1.57 on Nov 17, 2026, up 6.08% on the day. Over the past 52 weeks it traded between $1.39 and $112.04.
What is Park Ha Biological Technology's market cap?
Park Ha Biological Technology was worth $1.06M at the close on Nov 17, 2026: the share price times the diluted shares outstanding.
What is BYAH's P/E ratio?
Park Ha Biological Technology lost money over fiscal 2025 (diluted EPS -$41.38), so it has no meaningful P/E ratio.
How much revenue does Park Ha Biological Technology make?
Park Ha Biological Technology reported revenue of $2.52M for fiscal 2025, up 6.0% from a year earlier.
Does Park Ha Biological Technology pay a dividend?
No. Park Ha Biological Technology has not paid a cash dividend over the last twelve months.
How has BYAH stock performed over the past year?
Including dividends, BYAH returned -98.5% over the past year, against +11.2% for the S&P 500.
Who are Park Ha Biological Technology's competitors?
Companies most similar to Park Ha Biological Technology by business, industry and size include WNW, XAGE, DQWS, CSCIF, SHFH.
See a number that looks wrong?